Literature DB >> 16800024

A high efficiency cloning and expression system for proteomic analysis.

Xuan Z Ding1, Ian T Paulsen, Apurba K Bhattacharjee, Mikeljon P Nikolich, Gary Myers, David L Hoover.   

Abstract

The recent description of the complete genomes of the two most pathogenic species of Brucella opens the way for genome-based analysis of the antigenicity of their proteins. In the present report, we describe a bench-level high-efficiency cloning and expression system (HECES) that allow expression of large numbers of Brucella proteins based on genomic sequence information. Purified proteins are produced with high efficiency in a microarray format conducive to analysis of their sero-reactivity against serum from immunized animals. This method is applicable at either small or large scale of protein processing. While it does not require robotics, the format is amenable to robotic implementation for all aspects of the process and subsequent analysis of protein characteristics. This method will allow selection of new reagents for diagnosis of brucellosis and development of vaccine against Brucella, an important zoonotic disease and biothreat agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800024     DOI: 10.1002/pmic.200600047

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  2 in total

1.  The development of protein microarrays and their applications in DNA-protein and protein-protein interaction analyses of Arabidopsis transcription factors.

Authors:  Wei Gong; Kun He; Mike Covington; S P Dinesh-Kumar; Michael Snyder; Stacey L Harmer; Yu-Xian Zhu; Xing Wang Deng
Journal:  Mol Plant       Date:  2007-10-23       Impact factor: 13.164

2.  Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins.

Authors:  Amir Ghasemi; Mohammad Hossein Salari; Amir Hassan Zarnani; Mohammad Reza Pourmand; Hojat Ahmadi; Abbas Mirshafiey; Mahmood Jeddi-Tehrani
Journal:  Iran J Microbiol       Date:  2013-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.